Navigation Links
How will stem cell therapies impact patient care?

New Rochelle, NY, October 23, 2013The stem cell field is at a critical point, with the potential for a major impact on clinical medicine if stem cell-based therapies can overcome serious and immediate challenges. These challenges and key action items to overcome them are described in an article published on Fast Track as part of the World Stem Cell Report 2013, a special upcoming supplement to Stem Cells and Development, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. The article is available free on the Stem Cells and Development website.

The World Stem Cell Report is the official publication of the World Stem Cell Summit, to be held December 4-6, 2013 in San Diego, CA. More than 1,000 researchers and clinicians from around the globe will attend the Summit.

In the article "Key Action Items for the Stem Cell Field Looking to 2014," author Paul S. Knoepfler, University of California Davis School of Medicine, describes the building momentum behind stem cells, both for their impact as transformative basic science discoveries and their potential for translation to clinical medicine. At the same time, however, he outlines several critical challenges, including "stem cell tourism," the complex balance between innovation and regulatory/FDA compliance, and the need to educate physicians and patients about stem cell therapies.

"Paul Knoepfler is being honored at the World Stem Cell Summit with the Stem Cell Action 'National Advocacy Award' from the Genetics Policy Institute," says Bernard Siegel, JD, Co-Chair of the 2013 World Stem Cell Summit and Executive Director, Genetics Policy Institute (GPI, Palm Beach, FL). Siegel is also Co-Editor-in-Chief of the World Stem Cell Report."Dr. Knoepfler's unique perspective as a scientist and patient advocate provides a fresh perspective to the stem cell universe. As a communicator, Paul is unsurpassed. We are proud to include his views in the Report."

"Key opinion leaders in the field like Paul Knoepfler bring into focus where we are, and where we are not yet, in regard to the further translation of stem cell research," says Editor-in-Chief Graham C. Parker, PhD, The Carman and Ann Adams Department of Pediatrics, Wayne State University School of Medicine (Detroit, MI).


Contact: Vicki Cohn
Mary Ann Liebert, Inc./Genetic Engineering News

Related biology news :

1. New discoveries about brain-hand connection sought to improve therapies, treatments, prosthetics
2. Neural stem cell transplants for spinal cord injury maximized by combined, complimentary therapies
3. By adding VSL#3 probiotic to traditional therapies UC patients can improve remission rates
4. Stem cell transplantation into mouse cochlea may impact future hearing loss therapies
5. Zebra fish point the way towards new therapies for amyotrophic lateral sclerosis
6. Aging kidneys may hold key to new high blood pressure therapies
7. Therapies for spinal cord injury: On the cutting edge of clinical translation
8. Flu antibody’s one-handed grab may boost effort toward universal vaccine, new therapies
9. BioLife Solutions Products Now Used in More than 50 Clinical Trial-Stage Cellular Therapies
10. New technique could make cell-based immune therapies for cancer safer and more effective
11. Researchers discover genetic basis for eczema, new avenue to therapies
Post Your Comments:
Related Image:
How will stem cell therapies impact patient care?
(Date:10/29/2015)... 2015  Rubicon Genomics, Inc., today announced an ... its DNA library preparation products, including the ThruPLEX ... Plasma-seq kit. ThruPLEX Plasma-seq has been optimized for ... libraries for liquid biopsies--the analysis of cell-free circulating ... in cancer and other conditions. Eurofins Scientific is ...
(Date:10/29/2015)... Oct. 29, 2015 Today, LifeBEAM ... partnership with 2XU, a global leader in technical ... smart hat with advanced bio-sensing technology. The hat ... to monitor key biometrics to improve overall training ... the two companies will bring together the most advanced ...
(Date:10/27/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ), the ... has adopted the Synaptics ® ClearPad ® ... its newest flagship smartphones, the Nexus 5X by LG ... --> --> Synaptics works closely ... collaboration in the joint development of next generation technologies. ...
Breaking Biology News(10 mins):
(Date:11/24/2015)... Nov. 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ... New York on Wednesday, December 2 at ... , president and CEO, will provide a corporate overview. ... at 1:00 p.m. ET/10:00 a.m. PT . ... will provide a corporate overview. --> th Annual ...
(Date:11/24/2015)... -- Clintrax Global, Inc., a worldwide provider of clinical research services headquartered ... the company has set a new quarterly earnings record in Q3 ... posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , with ...
(Date:11/24/2015)... , November 24, 2015 ... market research report released by Transparency Market Research, the ... at a CAGR of 17.5% during the period between ... Market - Global Industry Analysis, Size, Volume, Share, Growth, ... non-invasive prenatal testing market to reach a valuation of ...
(Date:11/24/2015)... ... ... InSphero AG, the leading supplier of easy-to-use solutions for production, culture, and ... as Chief Operating Officer. , Having joined InSphero in November 2013 as ... promoted to Head of InSphero Diagnostics in 2014. There she has built up ...
Breaking Biology Technology: